FDLI's Introduction to Biologics and Biosimilars Law and Regulation

Partner Deborah Yellin and Senior Counsel Dr. Mary Anne Schofield, will be presenting "Biosimilar Biological Products" as part of the Food and Drug Law Institute’s Introduction to Biologics and Biosimilars Law and Regulation course in Washington, D.C., October 1-2. The two-day course explores the regulation of biological products, including biotechnology–derived therapeutic proteins, human tissue, gene, and cell products. Attendees will also gain a comprehensive understanding of the various administrative agencies that impact these industries.